References
1. Coronavirus COVID-19 global cases by the Center for Systems Science
and Engineering. Last accessed 3/29/20
(https://www.arcgis.com/apps/opsdashboard/index.html#/bda7594740fd40299423467b48e9ecf6).
2. Peckham h, de Gruijter N, Raine C, Radziszewska A, Ciurtin C,
Wedderburn LR, Rosser EC, Deakin C, Webb K. Sex-bias in COVID-19: a
meta-analysis and review of sex differences in disease and immunity.
Infectious Disease 2020. 10.21203/rs.3.rs-23651/v1
3. https://www.worldometers.info/coronavirus/coronavirus-symptoms/
4. Breslin N, Baptistec C, Miller R, Fuchs, K, Goffman D,
Gyamfi-Bannerman C, D’Alton M. COVID-19 in pregnancy: early lessons.
American Journal of Obstetrics and Gynecology 2020
5.
Breslin
N, Baptiste C, Gyamfi-Bannerman
C, Miller
R, Martinez
R, Bernstein
K, Ring
L, Landau
R, Purisch
S, Friedman
AM, Fuchs
K, Sutton
D, Andrikopoulou M, Rupley D,
Sheen
JJ, Aubey J, Zork N, Moroz L, Mourad M, Wapner
R, Simpson
LL, D’Alton ME, and Goffman D. COVID-19 infection among asymptomatic and
symptomatic pregnant women: Two weeks of confirmed presentations to an
affiliated pair of New York City hospitals. American Journal of
Obstetrics & Gynecology MFM. 9 April 2020, 100118
6. Wu C, Yang W, Wu X, Zhang T, Zhao Y, Ren W, Xia J. Clinical
manifestation and laboratory characteristics of SARS-CoV-2 infection in
pregnant women. Virol Sin . 2020 Apr 20. doi:
10.1007/s12250-020-00227-0
7. Yu N, Li W, Kang Q, Xiong Z, Wang S, Lin X, Liu Y, Xiao J, Liu H,
Deng D, Chen S, Zeng W, Feng L, Wu J. Clinical features and obstetric
and neonatal outcomes of pregnant patients with COVID-19 in Wuhan,
China: a retrospective, single-centre, descriptive study. Lancet Infect
Dis. 2020 May;20(5):559-564. doi: 10.1016/S1473-3099(20)30176-6.
8. Chen H, Guo J, Wang C, et al. Clinical characteristics and
intrauterine vertical transmission potential of COVID-19 infection in
nine pregnant women: a retrospective review of medical records. Lancet.
2020:395;809-815.
9. Sutton D, Fuchs K, D’Alton M, Goffman D. Universal Screening for
SARS-CoV-2 in Women Admitted for Delivery. New England Journal of
Medicine. DOI: 10.1056/NEJMc2009316
10. Luisi F., Petraglia, Benedetto C, Nappi RE, Bernardi F, Fadalti M,
Reis FM, Luisi M, and Genazzani AR. Serum Allopregnanolone Levels in
Pregnant Women: Changes during Pregnancy, at Delivery, and in
Hypertensive Patients
J
Clin Endocrinol Metab. 2000 Jul;85(7):2429-33.
11. Kurt D. Pennell, Mark A. Woodin, Page B. Pennell. Quantification of
neurosteroids during pregnancy using selective ion monitoring mass
spectrometry. Steroids 95 (2015) 24–31
12. Deligiannidis KM, Kroll-Desrosiers AR, Mo S, Nguyen HP, Svenson A,
Jaitly N, Hall JE, Barton BA, Rothschild AJ, Shaffer SA. Peripartum
neuroactive steroid and γ-aminobutyric acid profiles in women at-risk
for postpartum depression Psychoneuroendocrinology. 2016 Aug; 70:
98–107. doi: 10.1016/j.psyneuen.2016.05.010
13. Meltzer-Brody SE, Kanes SJ. Allopregnanolone in postpartum
depression: Role in pathophysiology and treatment. Neurobiology of
stress. https://doi.org/10.1016/j.ynstr.2020.1002129.
14. Paul SM, Pinna G, Guidotti A. “Allopregnanolone: From Molecular
Pathophysiology to Therapeutics - A Historical Perspective. Neurobiology
of Stress. 2020
DOI: 10.1016/j.ynstr.2020.100215
15. Locci A and Pinna G. Neurosteroid biosynthesis downregulation and
changes in GABAA receptor subunit composition: A biomarker axis in
stress-induced cognitive and emotional impairment. British Journal of
Pharmacology 174:3226-3241
16. Pinna G, Uzunova V, Matsumoto K, Puia G, Mienville JM, Costa E and
Guidotti A: Brain allopregnanolone regulates the potency of the
GABAA receptor agonist muscimol. Neuropharmacology
39:440-448. 2000.
17. Maguire JL, Stell BM, Mody I. Ovarian cycle‐linked changes in GABAA
receptors mediating tonic inhibition alter seizure susceptibility and
anxiety. Nat Neurosci 2005; 8: 797– 804.
18. Bloch M, Schmidt PJ, Danaceau M, Murphy J, Nieman L, Rubinow DR.
Effects of gonadal steroids in women with a history of postpartum
depression. Am J Psychiatry. 2000 Jun;157(6):924-30.
19. Wong CG, Bottiglieri T, Snead OC 3rd (2003) GABA,
gamma-hydroxybutyric acid, and neurological disease. Ann Neurol 54(Suppl
6):S3–S12.
20. Clarkson AN, Sutherland BA, Appleton I (2005) The biology and
pathology of hypoxiaischemia: An update. Arch Immunol Ther Exp (Warsz)
53:213–225.
21. Clarkson AN, et al. (2005) Clomethiazole: Mechanisms underlying
lasting neuroprotection following hypoxia-ischemia. FASEB J
19:1036–1038.
22. Reyes-Garcia MG, Hernandez-Hernandez F, Hernandez-Tellez B,
Garcia-Tamayo F (2007) GABA (A) receptor subunits RNA expression in mice
peritoneal macrophages modulate their IL-6/IL-12 production. J
Neuroimmunol 188:64–68.
23. Tian J, et al. (2004) Gamma-aminobutyric acid inhibits T cell
autoimmunity and the development of inflammatory responses in a mouse
type 1 diabetes model. J Immunol 173:5298–5304.
24. Alam S, Laughton DL, Walding A, Wolstenholme AJ (2006) Human
peripheral blood mononuclear cells express GABAA receptor subunits. Mol
Immunol 43:1432–1442
25. Bergeret M, et al. (1998) GABA modulates cytotoxicity of
immunocompetent cells expressing GABAA receptor subunits. Biomed
Pharmacother 52:214–219.
26. Bhat R, Axtell R, Mitra A, Miranda M, Lock C, Tsie RW, and Stein L.
Inhibitory role for GABA in autoimmune inflammation. Proc Natl Acad Sci
U S A. 2010 Feb 9;107(6):2580-5. doi: 10.1073/pnas.0915139107
27. Suresh K. Mendu, Amol Bhandage, Zhe Jin, Bryndis Birnir. Different
Subtypes of GABA-A Receptors Are Expressed in Human, Mouse and Rat T
Lymphocytes. https://doi.org/10.1371/journal.pone.0042959
28. Boero G, Porcu P, and A. Leslie Morrow. Pleiotropic actions of
allopregnanolone underlie therapeutic benefits in stress-related disease
Neurobiol Stress. 2020 May; 12: 100203. Published online 2019 Nov 27.
doi: 10.1016/j.ynstr.2019.100203
29. Balan I, Beattie MC, O’Buckley TK, Aurelian L, and Morrow AL.
Endogenous Neurosteroid (3α,5α)3-Hydroxypregnan-20-one Inhibits
Toll-like-4 Receptor Activation and Pro-inflammatory Signaling in
Macrophages and Brain Sci Rep. 2019; 9: 1220. Published online 2019 Feb
4. doi: 10.1038/s41598-018-37409-6
30. Nishel M. Shah, Pei F. Lai, Nesrina Imami, and Mark R. Johnson.
Progesterone-Related Immune Modulation of Pregnancy and Labor Front
Endocrinol (Lausanne). 2019; 10: 198. Published online 2019 Mar 29. doi:
10.3389/fendo.2019.00198
31. Hall, O., Klein, S. Progesterone-based compounds affect immune
responses and susceptibility to infections at diverse mucosal
sites. Mucosal Immunol 10, 1097–1107 (2017).
https://doi.org/10.1038/mi.2017.35
32. Vermillion MS, Nelson A, Vom Steeg L, Loube J, Mitzner W, Klein SL.
Pregnancy preserves pulmonary function following influenza virus
infection in C57BL/6 mice. Am J Physiol Lung Cell Mol Physiol. 2018 Oct
1;315(4):L517-L525. doi: 10.1152/ajplung.00066.2018. Epub 2018 May 31.
33. Goldfarb I , Berk T, Phillippe M. Pregnancy levels of estradiol and
progesterone modulate lung inflammation. AJO&G
DOI:https://doi.org/10.1016/j.ajog.2014.10.525
34. Maglione A, Rolla S, Mercanti SF, Cutrupi S, Clerico M. The Adaptive
Immune System in Multiple Sclerosis: An Estrogen-Mediated Point of View.
Cells. 2019 Oct 19;8(10). pii: E1280. doi: 10.3390/cells8101280.
35. Ghisletti S, Meda C, Maggi A, and Vegeto E. 17-Estradiol Inhibits
Inflammatory Gene Expression by Controlling NF-B Intracellular
Localization MOLECULAR AND CELLULAR BIOLOGY, Apr. 2005, p. 2957–2968
Vol. 25, No. 8 0270-7306/05/$08.000
doi:10.1128/MCB.25.8.2957–2968.2005
36. Gubbels Bupp, M.R.; Potluri, T.; Fink, A.L.; Klein, S.L. The
Confluence of Sex Hormones and Aging on Immunity. Front. Immunol. 2018,
9, 1269
37. Paris J, Liere P, Kim S, Mahdi F et al., Pregnane steroidogenesis is
altered by HIV-1 Tat and morphine: Physiological allopregnanolone is
protective against neurotoxic and psychomotor effects
https://doi.org/10.1016/j.ynstr.2020.100211
38. Maingat FG, Polyak MJ, Paul AM, Vivithanaporn P, Noorbakhsh F,
Ahboucha S, Baker GB, Pearson K, Power C. Neurosteroid-mediated
regulation of brain innate immunity in HIV/AIDS: DHEA-S suppresses
neurovirulence. Faseb. J., 27 (2013), pp. 725-737, 10.1096/fj.12-215079
39. Butler SA, Cole LA. Evidence for, and Associated Risks with, the
Human Chorionic Gonadotropin Supplemented Diet. J Diet Suppl. 2016
Nov;13(6):694-9. doi: 10.3109/19390211.2016.1156208. Epub 2016 Mar 24.
Review.
40. Pozzillia P and Lenzib A. Testosterone, a key hormone in the context
of COVID-19 pandemic Metabolism. 2020 Apr 27 : 154252. doi:
10.1016/j.metabol.2020.154252 [Epub ahead of print]